Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
News-Medical.Net on MSN
Innovative CRISPR strategy resensitizes lung cancer to treatment
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.
Banner Wyoming Medical Center is taking a major step forward in the fight against lung cancer. The hospital is launching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback